“Vietnam Healthy Lung” programme to be expanded for three years
Vietnamese patients with respiratory problems, especially lung cancer, will benefit from the second phase of the “Vietnam Healthy Lung” programme in 2021-23 that was signed between the health ministry’s Medical Services Administration (MSA) and AstraZeneca on November 16.
In the next three years, the programme will focus on raising public awareness of asthma, COPD and lung cancer for increasing screening and detection rates; increasing access to quality health services in terms of examination, diagnosis, treatment and disease management.
